InvestorsHub Logo

DewDiligence

02/02/15 5:23 PM

#186930 RE: masterlongevity #186929

Your 2015 total comes to $2.15B. I think they'll do at least $2.5B, with about 2/3 of that in the second half of the year. (I'm talking about worldwide numbers, not US only.)

justrpaul

02/02/15 6:11 PM

#186934 RE: masterlongevity #186929

250 million in December 2015 would give a 3B run rate. A steady build to 250 million in December could yield only 1.8 billion for 2015.

dewophile

02/02/15 7:47 PM

#186941 RE: masterlongevity #186929

enta may only hit the lower royalty rate in q1 which i can already see as a potential for negative sentiment. that and competitive data mid-year may present really good buying opportunities (i think enta is still going to make good money even with 3 players - especially since i see mrk cannabilizing gild relatively more than enta if they do have strong data with a qd offering)
PS: after mrk there isn't anyone else close to commercialization that i knwo of unless BMy resuscitates their program